Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. Check out why ...
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Boston Scientific (BSX), which belongs to ...
The latest trading session saw Boston Scientific (BSX) ending at $89.32, denoting a -0.4% adjustment from its last day's close. The stock exceeded the S&P 500, which registered a loss of 0.43% for the ...
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating on the shares as ...
Devices already in inventory can be used with the updated instructions by doctors. Patients already treated don’t need to do ...
This was the stock's fifth consecutive day of gains.
The stock's fall snapped a five-day winning streak.